By Andrew Silver SHANGHAI, June 29 (Reuters) - GLP-1 drugs from Pfizer and Innovent Biologics have passed a preliminary ...
Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.
Innovent will take over importing, marketing, and distributing Verzenios in mainland China as generic competition looms ...
SHANGHAI, June 30 (Reuters) - Innovent Biologics has entered into an agreement that grants it sole commercialization rights ...
BEIJING, June 29 () - Pfizer's GLP-1 drug Ecnoglutide and Innovent Biologics' mazdutide injection have passed a ...
IBI363 in combination with chemotherapy demonstrated encouraging efficacy signals and manageable safety in the first-line treatment of NSCLC with PD-L1 negative or low expression. The 3→1.5 mg/kg dose ...
Despite its massive $10.5 billion size and 12-drug scope, Pfizer’s oncology deal with Innovent Biologics took less than five months to forge, but not without undergoing some stress tests. The deal ...
YANG HAISHI/FOR CHINA DAILY Innovent Biologics has entered into a strategic collaboration with US pharmaceutical giant Eli ...
SAN FRANCISCO and SUZHOU, China, Oct. 14, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
SAN FRANCISCO and SUZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
The agreement covers eight early-stage trials from Innovent and four discovery programmes from global giant Pfizer China's Innovent Biologics has signed a global collaboration with pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results